Published in N Engl J Med on March 07, 1991
Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest (1993) 1.73
Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619. Br J Pharmacol (1993) 1.18
Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension. Thorax (1999) 1.07
The effect of i.v. sumatriptan, a selective 5-HT1-receptor agonist on central haemodynamics and the coronary circulation. Br J Clin Pharmacol (1992) 1.06
Pharmacological reactivity of human epicardial coronary arteries: phasic and tonic responses to vasoconstrictor agents differentiated by nifedipine. Br J Pharmacol (1994) 1.02
Serotonin and acute ischemic heart disease. N Engl J Med (1991) 1.00
Anaphylaxis from wasp stings inducing coronary thrombus. Case Rep Cardiol (2012) 0.92
Mechanism of 5-hydroxytryptamine-induced coronary vasodilation assessed by direct detection of nitric oxide production in guinea-pig isolated heart. Br J Pharmacol (1996) 0.84
A most unusual acute coronary syndrome. Can J Cardiol (2006) 0.82
Resistive vessel function in coronary artery disease. Heart (1996) 0.81
A comparison of the contractile effects of 5-hydroxytryptamine, sumatriptan and MK-462 on human coronary artery in vitro. Br J Clin Pharmacol (1995) 0.79
Involvement of 5-HT1B receptors in collar-induced hypersensitivity to 5-hydroxytryptamine of the rabbit carotid artery. Br J Pharmacol (1999) 0.79
Coronary Artery Spasm. Curr Treat Options Cardiovasc Med (2000) 0.79
The mechanisms by which antidepressants may reduce coronary heart disease risk. BMC Cardiovasc Disord (2015) 0.77
Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro. Br J Pharmacol (1995) 0.77
Distinct and complementary roles for α and β isoenzymes of PKC in mediating vasoconstrictor responses to acutely elevated glucose. Br J Pharmacol (2016) 0.76
Influence of the endothelium, nitric oxide and serotonergic receptors on coronary vasomotor responses evoked by ergonovine in conscious dogs. Br J Pharmacol (1999) 0.76
Platelets and cardiac arrhythmia. Front Physiol (2010) 0.76
Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery. Br J Clin Pharmacol (2000) 0.75
5-hydroxytryptamine has an endothelium-derived hyperpolarizing factor-like effect on coronary flow in isolated rat hearts. J Biomed Sci (2015) 0.75
Serotonin and coronary artery disease. N Engl J Med (1991) 0.75
Enhanced p122RhoGAP/DLC-1 Expression Can Be a Cause of Coronary Spasm. PLoS One (2015) 0.75
Endothelium dependent and independent responses in coronary artery disease measured at angioplasty. Br Heart J (1993) 0.75
Phosphorylated Myosin Light Chain 2 (p-MLC2) as a Molecular Marker of Antemortem Coronary Artery Spasm. Med Sci Monit (2016) 0.75
The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med (1994) 8.10
Glycosyltransferases: structures, functions, and mechanisms. Annu Rev Biochem (2008) 6.06
A classification of nucleotide-diphospho-sugar glycosyltransferases based on amino acid sequence similarities. Biochem J (1997) 5.86
Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation (1997) 5.16
Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet (1999) 4.36
Crystal structure of an N-terminal fragment of the DNA gyrase B protein. Nature (1991) 3.93
Nomenclature for sugar-binding subsites in glycosyl hydrolases. Biochem J (1997) 3.82
Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. N Engl J Med (1978) 3.42
"Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. Am J Cardiol (1978) 3.26
Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med (1996) 3.21
Perturbation of the T-cell repertoire in patients with unstable angina. Circulation (1999) 3.20
Myocardial cell death in human diabetes. Circ Res (2000) 3.12
Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation (1997) 2.95
Bowel function measurements of individuals with different eating patterns. Gut (1986) 2.92
Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol (1995) 2.89
Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation (1998) 2.75
Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J (2004) 2.71
Myocardial ischaemia during daily life in patients with stable angina: its relation to symptoms and heart rate changes. Lancet (1983) 2.70
Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci (Lond) (1998) 2.68
Elevated levels of interleukin-6 in unstable angina. Circulation (1996) 2.66
Intermittent coronary occlusion in acute myocardial infarction. Value of combined thrombolytic and vasodilator therapy. N Engl J Med (1987) 2.54
Catalysis by hen egg-white lysozyme proceeds via a covalent intermediate. Nature (2001) 2.51
Structure of the nucleotide-diphospho-sugar transferase, SpsA from Bacillus subtilis, in native and nucleotide-complexed forms. Biochemistry (1999) 2.43
Central nervous pathways mediating angina pectoris. Lancet (1994) 2.38
Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation (1999) 2.17
Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol (1991) 2.16
Major racial differences in coronary constrictor response between japanese and caucasians with recent myocardial infarction. Circulation (2000) 2.11
Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med (1994) 2.10
A census of carbohydrate-active enzymes in the genome of Arabidopsis thaliana. Plant Mol Biol (2001) 2.08
Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J (1982) 2.07
Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet (1996) 1.95
Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events. Circulation (1999) 1.94
Use of the radial artery for myocardial revascularization. Ann Thorac Surg (1996) 1.94
Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J Thromb Haemost (2014) 1.91
Myocardial ischemia caused by distal coronary-artery constriction in stable angina pectoris. N Engl J Med (1990) 1.89
Biodegradation of explosives by transgenic plants expressing pentaerythritol tetranitrate reductase. Nat Biotechnol (1999) 1.86
The natural history of left ventricular thrombus in myocardial infarction: a rationale in support of masterly inactivity. J Am Coll Cardiol (1989) 1.85
The X6 "thermostabilizing" domains of xylanases are carbohydrate-binding modules: structure and biochemistry of the Clostridium thermocellum X6b domain. Biochemistry (2000) 1.84
Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). N Engl J Med (1993) 1.81
Marked elevation of myocardial trace elements in idiopathic dilated cardiomyopathy compared with secondary cardiac dysfunction. J Am Coll Cardiol (1999) 1.75
Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans. Circulation (1993) 1.74
Crystal structure of the type-2 Cu depleted laccase from Coprinus cinereus at 2.2 A resolution. Nat Struct Biol (1998) 1.70
Stress, social support and health-related behavior: a study of smoking, alcohol consumption and physical exercise. J Psychosom Res (1996) 1.70
Glycoside hydrolases and glycosyltransferases. Families, modules, and implications for genomics. Plant Physiol (2000) 1.67
Angina pectoris: a headache. Lancet (2000) 1.66
Comparison of epicardial coronary artery tone and reactivity in Prinzmetal's variant angina and chronic stable angina pectoris. J Am Coll Cardiol (1991) 1.66
Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation (1999) 1.63
Role of adenosine in pathogenesis of anginal pain. Circulation (1990) 1.60
Rarefaction of skin capillaries in patients with anginal chest pain and normal coronary arteriograms. Eur Heart J (2001) 1.58
Evidence for a direct stimulatory effect of prostacyclin on renin release in man. J Clin Invest (1982) 1.57
Inflammation, atherosclerosis, and ischemic events -- exploring the hidden side of the moon. N Engl J Med (1997) 1.57
Management of unstable angina at rest by verapamil. A double-blind cross-over study in coronary care unit. Br Heart J (1979) 1.57
The C807T/G873A polymorphism in the platelet glycoprotein Ia gene and the risk of acute coronary syndrome in the Italian population. Br J Haematol (2001) 1.57
Coronary artery spasm and vasoconstriction. The case for a distinction. Circulation (1990) 1.55
Transient transmural reduction of myocardial blood flow demonstrated by thallium-201 scintigraphy, as a cause of variant angina. Circulation (1976) 1.54
Angiographic stenosis progression and coronary events in patients with 'stabilized' unstable angina. Circulation (1995) 1.54
Complications of carbenoxolone therapy. Br Med J (1974) 1.54
Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression. Eur Heart J (2001) 1.54
Effect of theophylline on exercise-induced myocardial ischaemia. Lancet (1989) 1.52
Enzymatic ketonization of 2-hydroxymuconate: specificity and mechanism investigated by the crystal structures of two isomerases. Biochemistry (1996) 1.52
Platelet aggregability in cardiac syndrome X. Eur Heart J (2001) 1.52
Sequence of events in angina at rest: primary reduction in coronary flow. Circulation (1980) 1.51
Allelic polymorphism of the interleukin-1 receptor antagonist gene in patients with acute or stable presentation of ischemic heart disease. Cardiologia (1999) 1.50
Vasoreactivity of the culprit lesion in unstable angina. Circulation (1994) 1.50
Epicardial coronary artery tone and reactivity in patients with normal coronary arteriograms and reduced coronary flow reserve (syndrome X) J Am Coll Cardiol (1991) 1.49
Elevated plasma lipoprotein(a) is associated with coronary artery disease in patients with chronic stable angina pectoris. J Am Coll Cardiol (1998) 1.48
Coronary artery spasm: demonstration, definition, diagnosis, and consequences. Prog Cardiovasc Dis (1983) 1.47
C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men. Eur Heart J (2000) 1.46
Failure to demonstrate myocardial ischaemia in patients with angina and normal coronary arteries. Evaluation by continuous coronary sinus pH monitoring and lactate metabolism. Eur Heart J (1996) 1.46
Crystal structure of the catalytic domain of a bacterial cellulase belonging to family 5. Structure (1995) 1.46
Dipyridamole-induced increased glucose uptake in patients with single-vessel coronary artery disease assessed with PET. J Nucl Cardiol (2001) 1.45
Autoantibodies against oxidized low density lipoproteins in patients with stable angina, unstable angina or peripheral vascular disease; pathophysiological implications. Eur Heart J (2001) 1.45
Reactivity of proximal and distal angiographically normal and stenotic coronary segments in chronic stable angina pectoris. Am J Cardiol (1991) 1.45
Angiographic characteristics of infarct-related and non-infarct-related stenoses in patients in whom stable angina progressed to acute myocardial infarction. Am Heart J (1998) 1.45
The hyperventilation test as a method for developing successful therapy in Prinzmetal's angina. Am J Cardiol (1982) 1.44
Tuberculous pericarditis with rapid progression to constriction. Prompt diagnosis and treatment are needed. BMJ (1993) 1.43
Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography. J Am Coll Cardiol (1997) 1.42
Clinical scores and patient risk stratification in non-ST elevation acute coronary syndrome. Int J Cardiol (2010) 1.41
Very early prediction of restenosis after successful coronary angioplasty: anatomic and functional assessment. J Am Coll Cardiol (1990) 1.41
Effect of magnesium sulphate in patients with unstable angina. A double blind, randomized, placebo-controlled study. Eur Heart J (1997) 1.41
Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart (2006) 1.40
Chest pain during daily life in patients with hypertrophic cardiomyopathy: an ambulatory electrocardiographic study. Eur Heart J (1996) 1.39
Variability of coronary blood flow reserve assessed by Doppler catheter after successful thrombolysis in patients with acute myocardial infarction. Am Heart J (1993) 1.39
Dipyridamole vasodilator response after human orthotopic heart transplantation: quantification by oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol (1992) 1.38
The crystal structure of the catalytic core domain of endoglucanase I from Trichoderma reesei at 3.6 A resolution, and a comparison with related enzymes. J Mol Biol (1997) 1.37
Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation (1998) 1.36
Impairment of myocardial perfusion and function during painless myocardial ischemia. J Am Coll Cardiol (1983) 1.35